ABOUT THE CONFERENCE
We are delighted to invite you to Pharma Extractables & Leachables Online Conference 2021, which will take place online on the 18th of February 2021 at 15:00 CET on BigMarker platform.
Join us for an event which offers a meeting place for top manufacturers, researchers, academics, decision-makers and other business professionals who are keen to share their knowledge and experience in newest strategies in Medical Devices industry and opportunities for further development.
The conference represents a unique opportunity for learning, exchanging opinions, and expanding one’s network enabled by live presentations followed by dynamic Q&A sessions – providing the attendees with valuable insights from specialists in the sphere of Medical Devices industry.
Key points
- Sustainability and E&L
- E&L analysis
- ISO 10993-16
- Prediction models for assessments E&L
Who should attend
SVPs, VPs, Directors & Heads, Team Leaders, Engineers & Scientists, Specialists, Managers and Consultants from:
- Bioprocessing
- Container Development
- Device Engineering Extractables and Leachables/E&L
- Materials Science and Selection
- Manufacturing Science and Technology
- Marketing & Business Development
- Product and Process Development
- Medical Devices
- Global Sales & Business Development
- Product Development
- CQ
- R&D
- QA/QC
- Safety and Risk Assessments
- Standardisation
- Testing
- Toxicology
- Analytical Chemist
- Pharmaceutical Analysis
- Regulatory Affairs
3-hour ONLINE CONFERENCE INCLUDES
- 3+ different topics
- panel discussion
- networking with business professionals and industry experts
- additional materials
15:00 – 15:10 CET
Welcome and opening remarks from the moderator
15:10 – 15:35 CET
Material and Chemical Characterization: The First Stage to Assess the Toxicological and Biological Risk Assessment of Medical Devices + Q&A
15:35 – 16:00 CET
chemical characterization & biological assessment of nanomaterials used in medical devices
16:00 – 16:05 CET
BREAK
16:05 – 16:30 CET
Medical Device Material Degradation and Identification - What is Sufficient for a Toxicological Risk Assessment + Q&A
16:30 – 17:00 CET
Panel Discussion: Perspective on E&L Analysis
17:00 – 17:05 CET
CLOSING SESSION REMARKS
SPEAKERS
